SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study
1. 系统已在2025-11-27 16:05:01对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1158/1078-0432.ccr-22-0346
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Jifeng Feng; Dihong Tang; Jing Wang; Qi Zhou; Jin Peng; Hanmei Lou; Yuping Sun; Yunlang Cai; Hongmin Chen; Junqin Yang; Pan Liu; Linna Wang; Jianjun Zou
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-22-0346/3163460/ccr-22-0346.pdf

